Table II.
Controls | Patients | |
---|---|---|
Total Numbers | 143 | 72 |
Gender | ||
Female | 56% | 54% |
Male | 44% | 46% |
Age | ||
18–25y | 30% | 38% |
26–40y | 41% | 33% |
>41 | 29% | 29% |
Race | ||
African American | 92% | 97% |
Caucasian | 7% | 3% |
Asian | <1% | 0 |
Controls | Patients | |
---|---|---|
Total Numbers | 143 | 72 |
Gender | ||
Female | 56% | 54% |
Male | 44% | 46% |
Age | ||
18–25y | 30% | 38% |
26–40y | 41% | 33% |
>41 | 29% | 29% |
Race | ||
African American | 92% | 97% |
Caucasian | 7% | 3% |
Asian | <1% | 0 |